Incyte
INCY
$51.18
Share price
-1.08%
Change (1 day)
-30.41%
Change (1 year)
Categories
Number of shares outstanding for Incyte (INCY)
Number of shares outstanding as of April 2024 : 224,078,000
According to Incyte's latest financial reports and stock price the company's current number of shares outstanding is 224,078,000. At the end of 2023 the company had 224,078,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Incyte from 2001 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 0.22 B | 0.66% |
| 2022 | 0.22 B | 0.74% |
| 2021 | 0.22 B | 0.8% |
| 2020 | 0.21 B | 1.61% |
| 2019 | 0.21 B | 1.29% |
| 2018 | 0.21 B | 0.89% |
| 2017 | 0.21 B | 11.94% |
| 2016 | 0.18 B | 1.25% |
| 2015 | 0.18 B | 9.62% |
| 2014 | 0.16 B | 4.95% |
| 2013 | 0.16 B | 22.93% |
| 2012 | 0.13 B | 4.32% |
| 2011 | 0.12 B | 3.33% |
| 2010 | 0.12 B | 24.64% |
| 2009 | 98.03 M | 6.11% |
| 2008 | 92.38 M | 9.7% |
| 2007 | 84.21 M | 0.43% |
| 2006 | 83.85 M | 0.53% |
| 2005 | 83.41 M | 13.76% |
| 2004 | 73.32 M | 1.58% |
| 2003 | 72.18 M | 6.56% |
| 2002 | 67.74 M | 2.06% |
| 2001 | 66.37 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 2,062,000,000 | 820.22% | 🇨🇭 Switzerland |
 Pfizer PFE | 5,647,000,000 | 2,420.10% | 🇺🇸 USA |
 Eli Lilly LLY | 949,379,000 | 323.68% | 🇺🇸 USA |
 Amgen AMGN | 535,000,000 | 138.76% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | 17,380,000 | -92.24% | 🇺🇸 USA |
 Geron GERN | 594,977,503 | 165.52% | 🇺🇸 USA |
 CTI BioPharma
CTIC | 131,566,000 | -41.29% | 🇺🇸 USA |
 AVEO Oncology
AVEO | 34,618,000 | -84.55% | 🇺🇸 USA |
 Ardelyx ARDX | 222,782,229 | -0.58% | 🇺🇸 USA |